Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis Clinical research trials and Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis. Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis clinical trial. Participants frequently get the best healthcare available for their Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "I" Clinical Trials Conditions > Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis

Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis



Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis

For Condition: Cystic Fibrosis
Status: Completed
Sponsor(s): InterMune ,
Synopsis: The purpose of this research study is to evaluate the safety and effectiveness of Interferon gamma-1b (IFN-g 1b) on lung function when given to patients with cystic fibrosis by inhalation (breathed into the lungs) three times a week for 12 weeks. The FDA has not approved Interferon gamma-1b for use with cystic fibrosis patients, which is the condition being examined in this study.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 12 Years/
Genders: Both
Protocol Entry Criteria: Key inclusion criteria: - At least 12 years of age - Diagnosis of cystic fibrosis with mild to moderate pulmonary impairment - Must be receiving ongoing chronic treatment with TOBI (inhaled tobramycin) OR not receiving ongoing chronic treatment with TOBI and no use of TOBI or other inhaled antibiotic within 4 weeks prior to study drug administration· - Other specific diagnostic indicators of CF and other factors must meet minimum requirements.
Total Enrollment: 60

Location and Contact Information:


Additional Information:
Study ID Numbers:  GICF-001; 
Study Start Date: February 2001
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043316

Other Cystic Fibrosis Studies:
1. Study of Hepatic Glucose Production and De novo Lipogenesis in Patients With Cystic Fibrosis

2. Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

3. Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

4. A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children with Cystic Fibrosis

5. Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

Related Studies:

Other Cystic Fibrosis Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials

Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis
Modify your Search

  Other Cystic Fibrosis Clinical Trials
  Other New York Clinical Trials
  Other New York City Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103